139 related articles for article (PubMed ID: 4686418)
1. Synthesis and pharmacology of a pargyline analog, N-3-(1-butynyl)-benzylamine.
Siuda JF; Cihonski C; Sofia RD; Buckley JP
J Pharm Sci; 1973 Feb; 62(2):331-2. PubMed ID: 4686418
[No Abstract] [Full Text] [Related]
2. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
Mills J; Kattau R; Slater IH; Fuller RW
J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
[No Abstract] [Full Text] [Related]
3. Allenic amines: a new class of nonhydrazine MAO inhibitors.
Halliday RP; Davis CS; Heotis JP; Pals DT; Watson EJ; Bickerton RK
J Pharm Sci; 1968 Mar; 57(3):430-3. PubMed ID: 5655581
[No Abstract] [Full Text] [Related]
4. Mitochondrial monoamine oxidase. Inactivation by pargyline. Adduct formation.
Chuang HY; Patek DR; Hellerman L
J Biol Chem; 1974 Apr; 249(8):2381-4. PubMed ID: 4822497
[No Abstract] [Full Text] [Related]
5. Substrate-selective and tissue-selective inhibition of monoamine oxidase.
Fuller RW; Roush BW
Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):270-6. PubMed ID: 5054735
[No Abstract] [Full Text] [Related]
6. Structure-activity relationships of monoamine oxidase inhibitors.
Fujita T
J Med Chem; 1973 Aug; 16(8):923-30. PubMed ID: 4745836
[No Abstract] [Full Text] [Related]
7. Differential effects of monoamine oxidase inhibitors.
Maickel RP; Rompalo AM; Cox RH
Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
[No Abstract] [Full Text] [Related]
8. Turnover rates of monoamine oxidases: recovery of the irreversibly inhibited enzyme activity and the influence of isoproterenol.
Planz G; Quiring K; Palm D
Life Sci I; 1972 Feb; 11(3):147-60. PubMed ID: 4653196
[No Abstract] [Full Text] [Related]
9. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
Abeles RH; Tashjian AH
Biochem Pharmacol; 1975 Jan; 24(2):307-8. PubMed ID: 1111545
[No Abstract] [Full Text] [Related]
10. Spontaneous peripheral leakage of pargyline on intracerebroventricular administration.
Ali B; Parmar SS; Seth PK; Brumleve SJ
Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1083-6. PubMed ID: 4760882
[No Abstract] [Full Text] [Related]
11. Antiarrhythmic agents. 2-, 3-, And 4-substituted benzylamines.
Remy DC; Van Saun WA; Engelhardt EL
J Med Chem; 1975 Feb; 18(2):142-8. PubMed ID: 1120980
[TBL] [Abstract][Full Text] [Related]
12. Effects of some biogenic amines on the blood pressure of pargyline-treated rabbits.
Airaksinen MM; Mustala O; Torsti P
Ann Med Exp Biol Fenn; 1966; 44(3):376-81. PubMed ID: 5958855
[No Abstract] [Full Text] [Related]
13. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
Stahl SM; Narotzky RA; Boshes B; Zeller EA
Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
[No Abstract] [Full Text] [Related]
14. Acetylenics. 2. Synthesis and pharmacology of certain N,N-diakyl-3-phenylpropyn-2-amines. Some analogues with tryptamine-like behavioral effects in mice.
Kwatra MM; Simon DZ; Salvador RL; Cooper PD
J Med Chem; 1978 Mar; 21(3):253-7. PubMed ID: 627999
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-n-2-propynyl-l-indanamine. A protent monoamine oxidase inhibitor.
Huebner CF; Donoghue EM; Plummer AJ; Furness PA
J Med Chem; 1966 Nov; 9(6):830-2. PubMed ID: 5972038
[No Abstract] [Full Text] [Related]
16. Inhibition of insulin release by substrates and inhibitors of monoamine oxidase.
Aleyassine H; Lee SH
Am J Physiol; 1972 Mar; 222(3):565-9. PubMed ID: 5022664
[No Abstract] [Full Text] [Related]
17. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
[No Abstract] [Full Text] [Related]
18. [Synthesis and pharmacology of N-aminoacyl-benzylamines].
Sidhu GS; Sattur PB; Sadanandam YS
Arch Pharm (Weinheim); 1973 Apr; 306(4):310-9. PubMed ID: 4716980
[No Abstract] [Full Text] [Related]
19. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
[No Abstract] [Full Text] [Related]
20. Dose-response effects of beta-phenylethylamine on stereotyped behavior in pargyline-pretreated rats.
Moja EA; Stoff DM; Gillin JC; Wyatt RJ
Biol Psychiatry; 1976 Dec; 11(6):731-42. PubMed ID: 1033771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
